Theratechnologies (THTX) Downgraded by Jones Trading | THTX Stock News

Theratechnologies (THTX, Financial) has experienced a notable shift in analyst sentiment as Jones Trading, a recognized name in financial analysis, has downgraded the stock. Previously rated as a “Buy”, the new rating for THTX is now “Hold”. This change was issued by analyst Justin Walsh and is reflective of the current market outlook as of July 3, 2025.

It is important to note that alongside the rating change, no new price target adjustments have been provided. Therefore, financial stakeholders should consider this rating update as a standalone assessment without any detailed price prediction guidance.

The report, released on July 3, 2025, did not go into specifics about the reasons behind the downgrade. Nevertheless, investors keen on monitoring Theratechnologies (THTX, Financial) should stay alert for any further updates or insights from Jones Trading and other analysts, which could provide a more comprehensive understanding of the company’s potential direction in the stock market.

Wall Street Analysts Forecast

Based on the one-year price targets offered by 2 analysts, the average target price for Theratechnologies Inc (THTX, Financial) is $3.90 with a high estimate of $4.00 and a low estimate of $3.80. The average target implies an upside of 64.90% from the current price of $2.37. More detailed estimate data can be found on the Theratechnologies Inc (THTX) Forecast page.

Based on the consensus recommendation from 2 brokerage firms, Theratechnologies Inc’s (THTX, Financial) average brokerage recommendation is currently 2.0, indicating “Outperform” status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for Theratechnologies Inc (THTX, Financial) in one year is $1.61, suggesting a downside of 31.92% from the current price of $2.365. GF Value is GuruFocus’ estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business’ performance. More detailed data can be found on the Theratechnologies Inc (THTX) Summary page.

MORE IN INSIDE INVESTMENT NEWS

Citigroup beats second-quarter estimates as markets and banking revenues jump

Published: Tuesday, July 15, 2025 · 12:38 PM

JPMorgan Chase tops estimates on stronger-than-expected trading, investment banking

Published: Tuesday, July 15, 2025 · 11:25 AM